Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

The Glucagon-Like Peptide-1 Analog, Liraglutide Is a Safe and Effective Treatment of Bile Acid Malabsorption: A Proof of Concept Study

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

DOI

  1. Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  2. The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  3. The Glucose-Lowering Effect of the Bile Acid Sequestrant Sevelamer Is Not Mediated by Glucagon-Like Peptide-1

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

View graph of relations
Original languageEnglish
Publication dateJun 2021
DOIs
Publication statusPublished - Jun 2021

ID: 74075741